文献速递母胎医学产科

162例胎儿心脏异常的遗传学特征及预后分析

[Genetic characteristics and prognostic analysis of 162 fetal cardiac abnormalities].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2022-01-01

回顾性分析北京大学第一医院2013年2月至2021年2月162例胎儿心脏异常孕妇的临床资料,致病性遗传学异常检出率为24.1%(39/162),孤立性心脏异常与伴心外异常胎儿检出率分别为16.3%(14/86)与32.9%(25/76),差异有统计学意义(χ2=6.094,P=0.014)。72例无致病性遗传学异常的孤立性心脏异常胎儿经临床预后评分评估,继续妊娠25例中24例(96.0%)健康存活。

要点

  • 产前超声发现胎儿心脏异常时推荐进一步行心脏及心外结构检查,同时行染色体核型分析及染色体微阵列分析,必要时行致病基因检测。
  • 孤立性心脏异常胎儿致病性遗传学异常检出率为16.3%(14/86),低于伴心外异常胎儿的32.9%(25/76)。
  • 无致病性遗传学异常的孤立性心脏异常胎儿应通过多学科协作进行临床预后评分评估。

核心结论

  • 产前超声发现胎儿心脏异常时推荐进一步行胎儿心脏及心外结构检查,同时行胎儿染色体核型分析及染色体微阵列分析,必要时行致病基因检测,以全面发现心脏和心外异常及遗传学异常。
  • 除外致病性遗传学异常及严重心外异常的胎儿,应对心脏异常胎儿进行多学科协作管理,进行充分的预后评估、全面地咨询和孕期管理,以改善母儿结局。

研究设计与样本

  • 回顾性分析2013年2月至2021年2月于北京大学第一医院产前诊断中心行遗传学检查的162例胎儿心脏异常孕妇的临床资料。
  • 遗传学检查方法包括染色体核型分析、基于微阵列的比较基因组杂交(aCGH)及致病基因检测。
  • 采用胎儿心脏出生缺陷临床预后评分系统对孤立性心脏异常且无致命性遗传学异常胎儿进行评估并随访预后。

主要发现

  • 162例中孤立性心脏异常86例(53.1%,86/162),心脏异常伴心外异常76例(46.9%,76/162);单发心脏异常84例(51.9%,84/162),多发心脏异常78例(48.1%,78/162)。
  • 共检出致病性遗传学异常39例(24.1%,39/162),包括染色体核型异常35例(21.6%,35/162)、致病性拷贝数变异(CNV)3例(1.9%,3/162)、致病基因变异1例(0.6%,1/162)。
  • 孤立性心脏异常胎儿与伴心外异常胎儿致病性遗传学异常检出率分别为16.3%(14/86)与32.9%(25/76),差异有统计学意义(χ2=6.094,P=0.014)。
  • 单发心脏异常胎儿致病性遗传学异常检出率为28.6%(24/84),其中室间隔缺损36.7%(11/30)、房室隔缺损8/13、法洛四联症3/17、永存动脉干1/1、心脏肿瘤1/1,其余单发心脏异常类型(共22例)未检出。
  • 主要致病性遗传学异常类型为21三体(41.7%,10/24)和18三体(41.7%,10/24)。

关键数值与推荐

  • 72例无致病性遗传学异常的孤立性心脏异常胎儿中,Ⅰ级4例均继续妊娠;Ⅱ级39例中引产21例、继续妊娠18例;Ⅲ级26例中引产23例、继续妊娠3例;Ⅳ级3例均引产。
  • 共引产47例,继续妊娠25例,目前24例(96.0%,24/25)均健康存活。
  • 产前超声发现胎儿心脏异常时推荐进一步行胎儿心脏及心外结构检查,同时行胎儿染色体核型分析及染色体微阵列分析,必要时行致病基因检测。
  • 除外致病性遗传学异常及严重心外异常的胎儿,应对心脏异常胎儿进行多学科协作管理,进行充分的预后评估、全面地咨询和孕期管理。

临床怎么用

  • 产前超声发现胎儿心脏异常时,推荐进一步行胎儿心脏及心外结构检查,同时行胎儿染色体核型分析及染色体微阵列分析,必要时行致病基因检测。
  • 除外致病性遗传学异常及严重心外异常的胎儿,应对心脏异常胎儿进行多学科协作管理,进行充分的预后评估、全面地咨询和孕期管理,以改善母儿结局。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To analyze the type and characteristics of fetal cardiac abnormalities and their relationships with genetic abnormalities and clinical prognosis. Methods: The clinical data of 162 pregnant women with fetal cardiac abnormalities who came to the prenatal diagnosis center of Peking University First Hospital and performed genetic tests from February 2013 to February 2021 were reviewed. Genetic testing methods included chromosome karyotype analysis, array-based comparative genomic hybridization (aCGH) and pathogenic gene detection. Fetuses with isolated cardiac abnormalities and no fatal genetic abnormalities were assessed using the fetal cardiac birth defects clinical outcome score and followed up. Results: (1) Ultrasonography results: among the 162 fetuses, 86 cases (53.1%, 86/162) had isolated cardiac abnormalities, and 76 cases (46.9%, 76/162) had extra-cardiac abnormalities; single cardiac abnormalities were in 84 (51.9%,84/162) cases, and multiple cardiac abnormalities occurred in 78 cases (48.1%,78/162). (2) Genetic examination results: there were 39 cases (24.1%, 39/162) of pathogenic genetic abnormalities, including 35 cases (21.6%, 35/162) of pathogenic chromosome karyotype abnormality, 3 cases (1.9%, 3/162) of pathogenic copy number variant (CNV), and 1 case (0.6%, 1/162) of pathogenic gene variation. The detection rates of pathogenic genetic abnormalities were 16.3% (14/86) in fetuses with isolated cardiac abnormalities and 32.9% (25/76) in fetuses with cardiac abnormalities and extra-cardiac abnormalities, and the difference was statistically significant (χ2=6.094, P=0.014). The detection rate of genetic abnormalities was 28.6% (24/84) in the single cardiac abnormalities, among which ventricular septal defect was 36.7% (11/30), atrioventricular septal defect was 8/13, tetralogy of Fallot was 3/17, persistent trancus arteriosus was 1/1, cardiac tumor was 1/1; no genetic abnormality was detected in the other single cardiac abnormality types (22 cases in total). The main types of pathogenic genetic abnormalities were trisomy 21 (41.7%, 10/24) and trisomy 18 (41.7%, 10/24). (3) Pregnancy outcome and fetal prognosis: among 72 fetuses with isolated heart abnormalities without pathogenic genetic abnormalities, there were 4 cases of grade Ⅰ, all of which continued pregnancy; 39 cases of grade Ⅱ, with 21 cases induced labor, 18 cases continued pregnancy; 26 cases of grade Ⅲ, with 23 cases induced labor, 3 cases continued pregnancy; 3 cases of grade Ⅳ, all of which induced labor. Totally, there were 47 cases induced labor and 25 cases continued pregnancy, 24 cases (96.0%, 24/25) of which were alive. Conclusions: When fetal cardiac abnormalities are detected by prenatal ultrasound, comprehensive cardiac and extra-cardiac ultrasound assessment and further genetic testing are recommended. Fetuses excluded pathogenic genetic abnormalities and extra-cardiac abnormalities should perform clinical prognostic score evaluation through multidisciplinary collaboration, to improve maternal and fetal outcomes. 目的: 探讨胎儿心脏异常的表现类型及其与遗传学异常及预后的关系。 方法: 收集2013年2月至2021年2月于北京大学第一医院进行产前检查发现胎儿心脏异常或因胎儿心脏异常转诊本院、行产前超声诊断为胎儿心脏异常,并且行遗传学检查的孕妇162例。遗传学检查方法包括染色体核型分析、基于微阵列的比较基因组杂交(aCGH)及致病基因检测。采用胎儿心脏出生缺陷临床预后评分系统对孤立性心脏异常且无致命性遗传学异常胎儿进行评估,并随访其预后。 结果: (1)超声检查结果:162例心脏异常胎儿中,孤立性心脏异常86例(53.1%,86/162),心脏异常伴心外异常76例(46.9%,76/162);单发心脏异常84例(51.9%,84/162),多发心脏异常78例(48.1%,78/162)。(2)遗传学检查结果:共检出致病性遗传学异常39例(24.1%,39/162),包括致病性染色体核型异常35例(21.6%,35/162),致病性拷贝数变异(CNV)3例(1.9%,3/162),致病基因变异1例(0.6%,1/162)。孤立性心脏异常胎儿与心脏异常伴心外异常胎儿致病性遗传学异常的检出率分别为16.3%(14/86)与32.9%(25/76),两者比较,差异有统计学意义(χ2=6.094,P=0.014)。单发心脏异常胎儿的致病性遗传学异常检出率为28.6%(24/84),其中室间隔缺损的检出率为36.7%(11/30),房室隔缺损为8/13,法洛四联症为3/17,永存动脉干为1/1,心脏肿瘤为1/1,其余单发心脏异常类型(共22例)未检出致病性遗传学异常;主要的致病性遗传学异常类型为21三体(41.7%,10/24)和18三体(41.7%,10/24)。(3)妊娠结局及胎儿预后:72例无致病性遗传学异常的孤立性心脏异常胎儿中,Ⅰ级4例,均继续妊娠;Ⅱ级39例,引产21例,继续妊娠18例;Ⅲ级26例,引产23例,继续妊娠3例;Ⅳ级3例,均引产。共引产47例,继续妊娠25例,目前24例(96.0%,24/25)均健康存活。 结论: 产前超声发现胎儿心脏异常时应进一步进行胎儿心脏及心外结构检查,同时行胎儿染色体核型分析及染色体微阵列分析,必要时行致病基因检测,从而全面发现心脏和心外异常及遗传学异常。除外致病性遗传学异常及严重心外异常的胎儿,应对心脏异常胎儿进行多学科协作管理,进行充分的预后评估,全面地咨询和孕期管理,以改善母儿结局。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li S, Liu Z. [Genetic characteristics and prognostic analysis of 162 fetal cardiac abnormalities]. Zhonghua Fu Chan Ke Za Zhi. 2022. PMID: 35902783. doi:10.3760/cma.j.cn112141-20220217-00101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。